Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02162251|
Recruitment Status : Completed
First Posted : June 12, 2014
Last Update Posted : September 7, 2018
Eisai Co., Ltd.
Information provided by (Responsible Party):
Eisai Inc. ( Eisai Co., Ltd. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||May 1, 2015|
|Actual Study Completion Date :||April 15, 2016|
Publications of Results:
Geriatric Medicine 55(1): 87-100, 2017.
Geriatric Medicine 55(11): 1251-1264, 2017.